tiprankstipranks
Fortress Biotech (FBIO)
NASDAQ:FBIO
US Market
FBIO
Fortress Biotech
RESEARCH TOOLSreports

Fortress Biotech (FBIO) Financial Statements

1,584 Followers

Fortress Biotech Financial Overview

Fortress Biotech's market cap is currently $75.68M. The company's EPS TTM is $-0.15; its P/E ratio is -6.48; Fortress Biotech is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 63.26M$ 57.67M$ 84.51M$ 75.74M$ 68.79M
Gross Profit$ 42.34M$ 36.80M$ 61.62M$ 44.97M$ 36.71M
Operating Income$ -70.22M$ -110.38M$ -142.34M$ -203.56M$ -188.54M
EBITDA$ -20.16M$ -104.49M$ -135.72M$ -193.69M$ -146.17M
Net Income$ 6.82M$ -46.00M$ -60.64M$ -86.58M$ -64.70M
Balance Sheet
Cash & Short-Term Investments$ 79.38M$ 57.26M$ 80.93M$ 178.27M$ 305.74M
Total Assets$ 185.55M$ 144.22M$ 167.53M$ 294.30M$ 396.50M
Total Debt$ 74.30M$ 75.96M$ 88.59M$ 127.34M$ 74.98M
Net Debt$ -5.08M$ 18.70M$ 7.67M$ -50.92M$ -230.77M
Total Liabilities$ 123.36M$ 145.87M$ 165.94M$ 244.28M$ 170.63M
Stockholders' Equity$ 49.87M$ 22.74M$ 22.54M$ 41.72M$ 108.67M
Cash Flow
Free Cash Flow$ -65.78M$ -95.19M$ -136.32M$ -182.46M$ -132.89M
Operating Cash Flow$ -65.78M$ -80.19M$ -128.22M$ -179.40M$ -116.54M
Investing Cash Flow$ 10.12M$ -15.00M$ -2.10M$ -22.93M$ 40.51M
Financing Cash Flow$ 77.44M$ 70.64M$ 32.74M$ 75.32M$ 148.99M
Currency in USD

Fortress Biotech Earnings and Revenue History

Income Statement >

Fortress Biotech Debt to Assets

Balance Sheet >

Fortress Biotech Cash Flow

Cash Flow >

Fortress Biotech Forecast EPS vs Actual EPS

Earnings >